MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer

Experienced CEO Brings Deep Oncology Drug Development and Company-Building Corporate Experience to Expand Growth in the U.S. CAMBRIDGE, Mass. and YAVNE, Israel, Sept. 9, 2020 -- (Healthcare Sales & Marketing Network) -- MetaboMed, a biopharmaceutical c... Biopharmaceuticals, Oncology, Personnel MetaboMed, cancer metabolism
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news